Drug intelligence / Profile preview

Oraltek

Development stage
Unknown
Lead developer
Inmunotek
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Sublingual
01

Overview

**Oraltek** is an INMUNOTEK-branded, prescription allergen-specific sublingual immunotherapy product line composed of glycerinated native allergen extracts administered as an under-the-tongue spray. Individual Oraltek preparations can contain clinically selected aeroallergen extracts, including house dust mites, pollens, animal epithelia, and fungi. Repeated sublingual exposure is intended to induce allergen-specific immune tolerance and reduce IgE-mediated respiratory allergic disease symptoms and rescue-medication requirements. The product is supplied as a pineapple-flavoured spray, commonly at 30,000 therapeutic units per mL, with maintenance dosing initiated on the first treatment day. INMUNOTEK manufactures Oraltek, and the product has been commercialized in China with HOB Biotech. ([inmunotek.com](https://www.inmunotek.com/en/extracts-and-vaccines/allergen-vaccines/))

Brand names
Oraltek
Other names
Oraltek perlingual spray
02

Targets

Blo t (Blomia tropicalis allergen)Der f (Dermatophagoides farinae allergens)

Beyond the preview

Go deeper on Oraltek.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oraltek.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call